# Intraoperative Imaging of Breast Cancer With Indocyanine Green

> **NCT01796041** · EARLY_PHASE1 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 10 (actual)

## Conditions studied

- Invasive Ductal Carcinoma
- Invasive Lobular Carcinoma
- Ductal Carcinoma

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT01796041
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2016-11-09
- **Final completion:** 2016-11-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796041, "Intraoperative Imaging of Breast Cancer With Indocyanine Green". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01796041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*